# 510(k) SUBSTANTIAL EQUIVALENCE DETERMINATION DECISION SUMMARY ASSAY ONLY TEMPLATE

A. 510(k) Number: k102210   
B. Purpose for Submission: New device   
C. Measurand: Amphetamine, Methamphetamine   
D. Type of Test: Qualitative and Semi-Quantitative Enzyme linked Immunoassay (ELISA)   
E. Applicant: Lin-Zhi International, Inc.   
F. Proprietary and Established Names: LZI Amphetamines 500 Homogeneous Enzyme Immunoassay LZI Amphetamines 500 Drugs of Abuse Calibrators LZI Amphetamines 500 Drugs of Abuse Controls

# G. Regulatory Information:

<table><tr><td rowspan=1 colspan=1>Product Code</td><td rowspan=1 colspan=1>Classification</td><td rowspan=1 colspan=1>Regulation Section</td><td rowspan=1 colspan=1>Panel</td></tr><tr><td rowspan=1 colspan=1>DKZ, enzyme immunoassay,amphetamine</td><td rowspan=1 colspan=1>Class II</td><td rowspan=1 colspan=1>21 CFR § 862.3100,Amphetamine test system</td><td rowspan=1 colspan=1>Toxicology(91)</td></tr><tr><td rowspan=1 colspan=1>DJC, thin layer chromatography,methamphetamine</td><td rowspan=1 colspan=1>Class II</td><td rowspan=1 colspan=1>21 CFR § 862.3610,Methamphetamine test system</td><td rowspan=1 colspan=1>Toxicology(91)</td></tr><tr><td rowspan=1 colspan=1>DLJ, calibrators, drug specific</td><td rowspan=1 colspan=1>Class II</td><td rowspan=1 colspan=1>21 CFR § 862.3200,Clinical toxicology calibrator.</td><td rowspan=1 colspan=1>Toxicology(91)</td></tr><tr><td rowspan=1 colspan=1>LAS, drug specific control materials</td><td rowspan=1 colspan=1>Class I</td><td rowspan=1 colspan=1>21 CFR § 862.3280,Clinical toxicology control material.</td><td rowspan=1 colspan=1>Toxicology(91)</td></tr></table>

# H. Intended Use:

1. Intended use(s): See indications for use below.

2. Indication(s) for use:

The LZI Amphetamines 500 Enzyme Immunoassay is intended for the qualitative and semi-quantitative determination of amphetamine and methamphetamine in human urine, at a cutoff value of $5 0 0 ~ \mathrm { { n g / m L } }$ when calibrated with dmethamphetamine. The assay is designed for professional use with a number of automated clinical chemistry analyzers.

The LZI Amphetamines 500 Drugs of Abuse (DAU) Calibrators are for use as calibrators in the qualitative and semi-quantitative calibration of the LZI Amphetamines Enzyme Immunoassay.

The LZI Amphetamines 500 Drugs of Abuse (DAU) Controls are for use as assayed quality control materials to monitor the precision of the LZI Amphetamines 500 Enzyme Immunoassay.

The assay provides only a preliminary analytical result. A more specific alternative chemical method must be used in order to obtain a confirmed analytical result. Gas or liquid chromatography/mass spectrometry (GC/MS or LC/MS) is the preferred confirmatory method). Clinical consideration and professional judgment should be exercised with any drug of abuse test result, particularly when the preliminary test result is positive.

3. Special conditions for use statement(s): For prescription use only.

4. Special instrument requirements:

Performance data was provided for Hitachi 717 analyzer. The assay can be used on a clinical chemistry analyzer capable of measuring absorbance at 340 nanometers.

# I. Device Description:

The LZI Amphetamines 500 Homogeneous Enzyme Immunoassay consists of two separately packaged reagents (R1 and R2):

<table><tr><td rowspan=1 colspan=1>Reagent</td><td rowspan=1 colspan=1>Description</td></tr><tr><td rowspan=1 colspan=1>R1</td><td rowspan=1 colspan=1>Contains two mouse monoclonal anti-amphetamines antibodies,glucose-6-phosphate (G6P), nicotinamide adenine dinucleotide (NAD),stabilizers and sodium azide as a preservative.</td></tr><tr><td rowspan=1 colspan=1>R2</td><td rowspan=1 colspan=1>Contains amphetamines-labeled glucose-6-phosphate dehydrogenase(G6PDH) in buffer with sodium azide as a preservative.</td></tr></table>

Each LZI Amphetamines 500 Drugs of Abuse Calibrator kit contains five calibrators comprised of a human urine matrix containing buffers, stabilizers and less than $0 . 1 \%$ of sodium azide. The controls are prepared by spiking known concentrations of dmethamphetamine into the drug-free matrix. The calibrators cover the calibration range of the assay (0 to $2 , 0 0 0 \mathrm { n g / m L }$ ) and are at the following concentrations:

<table><tr><td rowspan=1 colspan=1>Calibrator</td><td rowspan=1 colspan=1>Target Concentration(ng/mL)</td></tr><tr><td rowspan=1 colspan=1>Negative Calibrator</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=1 colspan=1>250ng/mLCalibrator</td><td rowspan=1 colspan=1>250</td></tr><tr><td rowspan=1 colspan=1>500ng/mLCalibrator</td><td rowspan=1 colspan=1>500</td></tr><tr><td rowspan=1 colspan=1>1000ng/mLCalibrator</td><td rowspan=1 colspan=1>1,000</td></tr><tr><td rowspan=1 colspan=1>2000 ng/mL Calibrator</td><td rowspan=1 colspan=1>2,000</td></tr></table>

Each LZI Amphetamines 500 Drugs of Abuse Control Kit contains two levels comprised of a human urine matrix containing buffers, stabilizers and less than $0 . 1 \%$ of sodium azide. The controls are prepared by spiking known concentrations of dmethamphetamine into the drug-free matrix. The controls are available at the following concentrations:

<table><tr><td rowspan=1 colspan=1>Control</td><td rowspan=1 colspan=1>Target Concentration(ng/mL)</td></tr><tr><td rowspan=1 colspan=1>375 ng/mL Control</td><td rowspan=1 colspan=1>375</td></tr><tr><td rowspan=1 colspan=1>625 ng/mL Control</td><td rowspan=1 colspan=1>625</td></tr></table>

# J. Substantial Equivalence Information:

<table><tr><td>Predicate device name</td><td>Predicate 510(k) number</td></tr><tr><td>LZI Amphetamines Enzyme Immunoassay</td><td>k020395</td></tr></table>

Comparison with predicate:   

<table><tr><td colspan="3" rowspan="1">Similarities and Differences</td></tr><tr><td colspan="1" rowspan="1">Item</td><td colspan="1" rowspan="1">Device</td><td colspan="1" rowspan="1">Predicate (k020395)</td></tr><tr><td colspan="1" rowspan="1">Indications forUse</td><td colspan="1" rowspan="1">The LZI Amphetamines 500 EnzymeImmunoassay is intended for thequalitative and semi-quantitativedetermination of amphetamine andmethamphetamine in human urine, at acutoff value of 500 ng/mL whencalibrated with d-methamphetamine.The assay is designed for professionaluse with a number of automated clinicalchemistry analyzers.The assay provides only a preliminaryanalytical result. A more specificalternative chemical method must beused in order to obtain a confirmedanalytical result. Gas or liquidchromatography/mass spectrometry(GC/MS or LC/MS) is the preferredconfirmatory method. Clinicalconsideration and professional judgmentshould be exercised with any drug ofabuse test result, particularly when thepreliminary test result is positive.</td><td colspan="1" rowspan="1">The LZI Amphetamines EnzymeImmunoassay, when used inconjunction with Hitachi 717 automatedclinical system analyzers, is intended forthe qualitative and semi-quantitativedetermination of Amphetamines inhuman urine, at a cutoff value of 1000ng/mL. The assay is designed forprofessional use with a number ofautomated clinical chemistry analyzers.The assay provides only a preliminaryanalytical result. A more specificalternative chemical method must beused in order to obtain a confirmedanalytical result. Gas or liquidchromatography/mass spectrometry(GC/MS or LC/MS) is the preferredconfirmatory method. Clinicalconsideration and professional judgmentshould be exercised with any drug ofabuse test result, particularly when thepreliminary test result is positive.</td></tr><tr><td colspan="1" rowspan="1">Analyte</td><td colspan="1" rowspan="1">d-amphetamine and d-methamphetamine</td><td colspan="1" rowspan="1">Amphetamines</td></tr><tr><td colspan="1" rowspan="1">Assay Type</td><td colspan="1" rowspan="1">Same</td><td colspan="1" rowspan="1">Qualitative and Semi-Quantitative</td></tr><tr><td colspan="1" rowspan="1">Cutoff value</td><td colspan="1" rowspan="1">500 ng/mL</td><td colspan="1" rowspan="1">1000 ng/ml</td></tr><tr><td colspan="1" rowspan="1">Sample</td><td colspan="1" rowspan="1">Same</td><td colspan="1" rowspan="1">Urine</td></tr><tr><td colspan="1" rowspan="1">Methodology</td><td colspan="1" rowspan="1">Same</td><td colspan="1" rowspan="1">Enzyme linked Immunoassay (ELISA)</td></tr><tr><td colspan="1" rowspan="1">Test Principle</td><td colspan="1" rowspan="1">Same</td><td colspan="1" rowspan="1">The assay is an Enzyme linkedImmunoassay (ELISA) based oncompetition between drug(amphetamine and methamphetamine)in the sample and drug labeled with theenzyme glucose-6-phosphatedehydrogenase (G6PDH) for a fixedamount of antibody in the reagent.Enzyme activity decreases upon bindingto the antibody, and the drugconcentration in the sample is measuredin terms of enzyme activity. In theabsence of drug in the sample,buprenorphine-labeled G6PDHconjugate is bound to antibody, and theenzyme activity is inhibited. On theother hand, when free drug is present inthe sample, antibody would bind to freedrug, the unbound amphetamine-labeledG6PDH then exhibits its maximalenzyme activity. Active enzymeconverts nicotinamide adeninedinucleotide (NAD) to NADH, resultingin an absorbance change that can bemeasured spectrophotometrically at 340nm.</td></tr><tr><td colspan="1" rowspan="1">Analyzer</td><td colspan="1" rowspan="1">Same</td><td colspan="1" rowspan="1">Clinical chemistry analyzer capable ofmeasuring absorbance at 340nanometers.</td></tr><tr><td colspan="1" rowspan="1">DetectionWavelength</td><td colspan="1" rowspan="1">Same</td><td colspan="1" rowspan="1">340 nanometers</td></tr><tr><td colspan="1" rowspan="1">Calibrators</td><td colspan="1" rowspan="1">Five Levels (0, 250, 500, 1000 and2000 ng/mL)</td><td colspan="1" rowspan="1">Five Levels (0, 500, 1000, 1500, 2000ng/mL)</td></tr><tr><td colspan="1" rowspan="1">Controls</td><td colspan="1" rowspan="1">Two Levels (375 and 625 ng/mL)</td><td colspan="1" rowspan="1">Two Levels (750 and 1250 ng/mL)</td></tr></table>

# K. Standard/Guidance Document Referenced (if applicable):

EP5-A, Evaluation of Precision Performance of Clinical Chemistry Devices

# L. Test Principle:

The assay is an Enzyme linked Immunoassay (ELISA) based on competition between drug (amphetamine and methamphetamine) in the sample and drug labeled with the enzyme glucose-6-phosphate dehydrogenase (G6PDH) for a fixed amount of antibody in the reagent. Enzyme activity decreases upon binding to the antibody, and the drug concentration in the sample is measured in terms of enzyme activity. In the absence of drug in the sample, buprenorphine-labeled G6PDH conjugate is bound to antibody, and the enzyme activity is inhibited. On the other hand, when free drug is present in the sample, antibody would bind to free drug, the unbound amphetaminelabeled G6PDH then exhibits its maximal enzyme activity. Active enzyme converts nicotinamide adenine dinucleotide (NAD) to NADH, resulting in an absorbance change that can be measured spectrophotometrically at $3 4 0 \mathrm { n m }$ .

# M. Performance Characteristics (if/when applicable):

1. Analytical performance:

# a. Precision/Reproducibility:

The sponsor conducted two separate precision studies on the Hitachi 717 analyzer using samples containing $\mathrm { d }$ -methamphetamine or ${ \mathrm { d } } .$ -amphetamine. The precision studies were performed according to CLSI EP5-A2. Samples were prepared by spiking a negative human urine pool with either dmethamphetamine or ${ \mathrm { d } } \cdot { }$ -amphetamine at the following concentrations: zero drug $( - 1 0 0 \% )$ , $- 7 5 \%$ , $- 5 0 \%$ , and $- 2 5 \%$ below the cutoff, cutoff, and $+ 2 5 \%$ , $+ 5 0 \%$ , $+ 7 5 \%$ , and $+ 1 0 0 \%$ above the cutoff. Samples were tested in 2 replicates per run, 2 runs per day for 22 days, total $\scriptstyle \mathrm { n = } 8 8$ . Results of the studies are presented below:

Semi-Quantitative Precision Data for d-amphetamine   

<table><tr><td rowspan=1 colspan=2>500 ng/mL Cutoff Result</td><td rowspan=1 colspan=2>Within Run</td><td rowspan=1 colspan=2>Total Precision</td></tr><tr><td rowspan=1 colspan=1>SampleConcentration(ng/mL)</td><td rowspan=1 colspan=1>% of Cutoff</td><td rowspan=1 colspan=1>Number ofDeterminations</td><td rowspan=1 colspan=1>ImmunoassayResult</td><td rowspan=1 colspan=1>Number ofDeterminations</td><td rowspan=1 colspan=1>ImmunoassayResult</td></tr><tr><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>-100%</td><td rowspan=1 colspan=1>22</td><td rowspan=1 colspan=1>22 Negative</td><td rowspan=1 colspan=1>88</td><td rowspan=1 colspan=1>88 Negative</td></tr><tr><td rowspan=1 colspan=1>125</td><td rowspan=1 colspan=1>-75%</td><td rowspan=1 colspan=1>22</td><td rowspan=1 colspan=1>22 Negative</td><td rowspan=1 colspan=1>88</td><td rowspan=1 colspan=1>88 Negative</td></tr><tr><td rowspan=1 colspan=1>250</td><td rowspan=1 colspan=1>-50%</td><td rowspan=1 colspan=1>22</td><td rowspan=1 colspan=1>22 Negative</td><td rowspan=1 colspan=1>88</td><td rowspan=1 colspan=1>88 Negative</td></tr><tr><td rowspan=1 colspan=1>375</td><td rowspan=1 colspan=1>-25%</td><td rowspan=1 colspan=1>22</td><td rowspan=1 colspan=1>22 Negative</td><td rowspan=1 colspan=1>88</td><td rowspan=1 colspan=1>88 Negative</td></tr><tr><td rowspan=1 colspan=1>500</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>22</td><td rowspan=1 colspan=1>22 Positive</td><td rowspan=1 colspan=1>88</td><td rowspan=1 colspan=1>83 Positive5 Negative</td></tr><tr><td rowspan=1 colspan=1>625</td><td rowspan=1 colspan=1>+25%</td><td rowspan=1 colspan=1>22</td><td rowspan=1 colspan=1>22 Positive</td><td rowspan=1 colspan=1>88</td><td rowspan=1 colspan=1>88 Positive</td></tr><tr><td rowspan=1 colspan=1>750</td><td rowspan=1 colspan=1>+50%</td><td rowspan=1 colspan=1>22</td><td rowspan=1 colspan=1>22 Positive</td><td rowspan=1 colspan=1>88</td><td rowspan=1 colspan=1>88 Positive</td></tr><tr><td rowspan=1 colspan=1>875</td><td rowspan=1 colspan=1>+75%</td><td rowspan=1 colspan=1>22</td><td rowspan=1 colspan=1>22 Positive</td><td rowspan=1 colspan=1>88</td><td rowspan=1 colspan=1>88 Positive</td></tr><tr><td rowspan=1 colspan=1>1000</td><td rowspan=1 colspan=1>+100%</td><td rowspan=1 colspan=1>22</td><td rowspan=1 colspan=1>22 Positive</td><td rowspan=1 colspan=1>88</td><td rowspan=1 colspan=1>88 Positive</td></tr></table>

Qualitative Precision Data for ${ \mathrm { d } } \cdot { }$ -amphetamine   

<table><tr><td colspan="2" rowspan="1">500 ng/mL Cutoff Result</td><td colspan="2" rowspan="1">Within Run</td><td colspan="2" rowspan="1">Total Precision</td></tr><tr><td colspan="1" rowspan="1">SampleConcentration(ng/mL)</td><td colspan="1" rowspan="1">% of Cutoff</td><td colspan="1" rowspan="1">Number ofDeterminations</td><td colspan="1" rowspan="1">ImmunoassayResult</td><td colspan="1" rowspan="1">Number ofDeterminations</td><td colspan="1" rowspan="1">ImmunoassayResult</td></tr><tr><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">-100%</td><td colspan="1" rowspan="1">22</td><td colspan="1" rowspan="1">22 Negative</td><td colspan="1" rowspan="1">88</td><td colspan="1" rowspan="1">88 Negative</td></tr><tr><td colspan="1" rowspan="1">125</td><td colspan="1" rowspan="1">-75%</td><td colspan="1" rowspan="1">22</td><td colspan="1" rowspan="1">22 Negative</td><td colspan="1" rowspan="1">88</td><td colspan="1" rowspan="1">88 Negative</td></tr><tr><td colspan="1" rowspan="1">250</td><td colspan="1" rowspan="1">-50%</td><td colspan="1" rowspan="1">22</td><td colspan="1" rowspan="1">22 Negative</td><td colspan="1" rowspan="1">88</td><td colspan="1" rowspan="1">88 Negative</td></tr><tr><td colspan="1" rowspan="1">375</td><td colspan="1" rowspan="1">-25%</td><td colspan="1" rowspan="1">22</td><td colspan="1" rowspan="1">22 Negative</td><td colspan="1" rowspan="1">88</td><td colspan="1" rowspan="1">88 Negative</td></tr><tr><td colspan="1" rowspan="1">500</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">22</td><td colspan="1" rowspan="1">15 Positive</td><td colspan="1" rowspan="1">88</td><td colspan="1" rowspan="1">48 Positive</td></tr><tr><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">7 Negative</td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">40 Negative</td></tr><tr><td colspan="1" rowspan="1">625</td><td colspan="1" rowspan="1">+25%</td><td colspan="1" rowspan="1">22</td><td colspan="1" rowspan="1">22 Positive</td><td colspan="1" rowspan="1">88</td><td colspan="1" rowspan="1">88 Positive</td></tr><tr><td colspan="1" rowspan="1">750</td><td colspan="1" rowspan="1">+50%</td><td colspan="1" rowspan="1">22</td><td colspan="1" rowspan="1">22 Positive</td><td colspan="1" rowspan="1">88</td><td colspan="1" rowspan="1">88 Positive</td></tr><tr><td colspan="1" rowspan="1">875</td><td colspan="1" rowspan="1">+75%</td><td colspan="1" rowspan="1">22</td><td colspan="1" rowspan="1">22 Positive</td><td colspan="1" rowspan="1">88</td><td colspan="1" rowspan="1">88 Positive</td></tr><tr><td colspan="1" rowspan="1">1000</td><td colspan="1" rowspan="1">+100%</td><td colspan="1" rowspan="1">22</td><td colspan="1" rowspan="1">22 Positive</td><td colspan="1" rowspan="1">88</td><td colspan="1" rowspan="1">88 Positive</td></tr></table>

Semi-Quantitative Precision Data for d-methamphetamine   

<table><tr><td rowspan=1 colspan=2>500 ng/mL Cutoff Result</td><td rowspan=1 colspan=2>Within Run</td><td rowspan=1 colspan=2>Total Precision</td></tr><tr><td rowspan=1 colspan=1>SampleConcentration(ng/mL)</td><td rowspan=1 colspan=1>% of Cutoff</td><td rowspan=1 colspan=1>Number ofDeterminations</td><td rowspan=1 colspan=1>ImmunoassayResult</td><td rowspan=1 colspan=1>Number ofDeterminations</td><td rowspan=1 colspan=1>ImmunoassayResult</td></tr><tr><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>-100%</td><td rowspan=1 colspan=1>22</td><td rowspan=1 colspan=1>22 Negative</td><td rowspan=1 colspan=1>88</td><td rowspan=1 colspan=1>88 Negative</td></tr><tr><td rowspan=1 colspan=1>125</td><td rowspan=1 colspan=1>-75%</td><td rowspan=1 colspan=1>22</td><td rowspan=1 colspan=1>22 Negative</td><td rowspan=1 colspan=1>88</td><td rowspan=1 colspan=1>88 Negative</td></tr><tr><td rowspan=1 colspan=1>250</td><td rowspan=1 colspan=1>-50%</td><td rowspan=1 colspan=1>22</td><td rowspan=1 colspan=1>22 Negative</td><td rowspan=1 colspan=1>88</td><td rowspan=1 colspan=1>88 Negative</td></tr><tr><td rowspan=1 colspan=1>375</td><td rowspan=1 colspan=1>-25%</td><td rowspan=1 colspan=1>22</td><td rowspan=1 colspan=1>22 Negative</td><td rowspan=1 colspan=1>88</td><td rowspan=1 colspan=1>88 Negative</td></tr><tr><td rowspan=1 colspan=1>500</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>22</td><td rowspan=1 colspan=1>3 Positive19 Negative</td><td rowspan=1 colspan=1>88</td><td rowspan=1 colspan=1>18 Positive70 Negative</td></tr><tr><td rowspan=1 colspan=1>625</td><td rowspan=1 colspan=1>+25%</td><td rowspan=1 colspan=1>22</td><td rowspan=1 colspan=1>22 Positive</td><td rowspan=1 colspan=1>88</td><td rowspan=1 colspan=1>88 Positive</td></tr><tr><td rowspan=1 colspan=1>750</td><td rowspan=1 colspan=1>+50%</td><td rowspan=1 colspan=1>22</td><td rowspan=1 colspan=1>22 Positive</td><td rowspan=1 colspan=1>88</td><td rowspan=1 colspan=1>88 Positive</td></tr><tr><td rowspan=1 colspan=1>875</td><td rowspan=1 colspan=1>+75%</td><td rowspan=1 colspan=1>22</td><td rowspan=1 colspan=1>22 Positive</td><td rowspan=1 colspan=1>88</td><td rowspan=1 colspan=1>88 Positive</td></tr><tr><td rowspan=1 colspan=1>1000</td><td rowspan=1 colspan=1>+100%</td><td rowspan=1 colspan=1>22</td><td rowspan=1 colspan=1>22 Positive</td><td rowspan=1 colspan=1>88</td><td rowspan=1 colspan=1>88 Positive</td></tr></table>

Qualitative Precision Data for $\mathrm { d }$ -methamphetamine   

<table><tr><td rowspan=1 colspan=2>500 ng/mL Cutoff Result</td><td rowspan=1 colspan=2>Within Run</td><td rowspan=1 colspan=2>Total Precision</td></tr><tr><td rowspan=1 colspan=1>SampleConcentration(ng/mL)</td><td rowspan=1 colspan=1>% of Cutoff</td><td rowspan=1 colspan=1>Number ofDeterminations</td><td rowspan=1 colspan=1>ImmunoassayResult</td><td rowspan=1 colspan=1>Number ofDeterminations</td><td rowspan=1 colspan=1>ImmunoassayResult</td></tr><tr><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>-100%</td><td rowspan=1 colspan=1>22</td><td rowspan=1 colspan=1>22 Negative</td><td rowspan=1 colspan=1>88</td><td rowspan=1 colspan=1>88 Negative</td></tr><tr><td rowspan=1 colspan=1>125</td><td rowspan=1 colspan=1>-75%</td><td rowspan=1 colspan=1>22</td><td rowspan=1 colspan=1>22 Negative</td><td rowspan=1 colspan=1>88</td><td rowspan=1 colspan=1>88 Negative</td></tr><tr><td rowspan=1 colspan=1>250</td><td rowspan=1 colspan=1>-50%</td><td rowspan=1 colspan=1>22</td><td rowspan=1 colspan=1>22 Negative</td><td rowspan=1 colspan=1>88</td><td rowspan=1 colspan=1>88 Negative</td></tr><tr><td rowspan=1 colspan=1>375</td><td rowspan=1 colspan=1>-25%</td><td rowspan=1 colspan=1>22</td><td rowspan=1 colspan=1>22 Negative</td><td rowspan=1 colspan=1>88</td><td rowspan=1 colspan=1>88 Negative</td></tr><tr><td rowspan=1 colspan=1>500</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>22</td><td rowspan=1 colspan=1>13 Positive9 Negative</td><td rowspan=1 colspan=1>88</td><td rowspan=1 colspan=1>54 Positive34 Negative</td></tr><tr><td rowspan=1 colspan=1>625</td><td rowspan=1 colspan=1>+25%</td><td rowspan=1 colspan=1>22</td><td rowspan=1 colspan=1>22 Positive</td><td rowspan=1 colspan=1>88</td><td rowspan=1 colspan=1>88 Positive</td></tr><tr><td rowspan=1 colspan=1>750</td><td rowspan=1 colspan=1>+50%</td><td rowspan=1 colspan=1>22</td><td rowspan=1 colspan=1>22 Positive</td><td rowspan=1 colspan=1>88</td><td rowspan=1 colspan=1>88 Positive</td></tr><tr><td rowspan=1 colspan=1>875</td><td rowspan=1 colspan=1>+75%</td><td rowspan=1 colspan=1>22</td><td rowspan=1 colspan=1>22 Positive</td><td rowspan=1 colspan=1>88</td><td rowspan=1 colspan=1>88 Positive</td></tr><tr><td rowspan=1 colspan=1>1000</td><td rowspan=1 colspan=1>+100%</td><td rowspan=1 colspan=1>22</td><td rowspan=1 colspan=1>22 Positive</td><td rowspan=1 colspan=1>88</td><td rowspan=1 colspan=1>88 Positive</td></tr></table>

# b. Linearity/assay reportable range:

Linearity across the range was confirmed in two separate studies by serially diluting a spiked urine pool containing d-methamphetamine or d-amphetamine in desired levels listed in the table below. Each sample was assayed in 10 replicates on Hitachi 717 analyzer in the semi-quantitative mode. The results were averaged and compared to the expected result and the percent recovery was calculated. Results are presented below:

<table><tr><td colspan="3" rowspan="1">Linearity Data for d-amphetamine</td><td colspan="3" rowspan="1">Linearity Data for d-methamphetamine</td></tr><tr><td colspan="1" rowspan="1">Expected</td><td colspan="1" rowspan="1">Observed</td><td colspan="1" rowspan="1">% Recovery</td><td colspan="1" rowspan="1">Expected</td><td colspan="1" rowspan="1">Observed</td><td colspan="1" rowspan="1">% Recovery</td></tr><tr><td colspan="1" rowspan="1">Value(ng/mL)</td><td colspan="1" rowspan="1">Value(ng/mL)</td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">Value(ng/mL)</td><td colspan="1" rowspan="1">Value(ng/mL)</td><td colspan="1" rowspan="1"></td></tr><tr><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">4.1</td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">5.7</td><td colspan="1" rowspan="1"></td></tr><tr><td colspan="1" rowspan="1">25</td><td colspan="1" rowspan="1">30.1</td><td colspan="1" rowspan="1">120%</td><td colspan="1" rowspan="1">25</td><td colspan="1" rowspan="1">36.0</td><td colspan="1" rowspan="1">144%</td></tr><tr><td colspan="1" rowspan="1">150</td><td colspan="1" rowspan="1">193.7</td><td colspan="1" rowspan="1">129%</td><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">56.2</td><td colspan="1" rowspan="1">112%</td></tr><tr><td colspan="1" rowspan="1">300</td><td colspan="1" rowspan="1">346.6</td><td colspan="1" rowspan="1">116%</td><td colspan="1" rowspan="1">200</td><td colspan="1" rowspan="1">205.8</td><td colspan="1" rowspan="1">103%</td></tr><tr><td colspan="1" rowspan="1">400</td><td colspan="1" rowspan="1">438.9</td><td colspan="1" rowspan="1">110%</td><td colspan="1" rowspan="1">300</td><td colspan="1" rowspan="1">293.6</td><td colspan="1" rowspan="1">97.9%</td></tr><tr><td colspan="1" rowspan="1">500</td><td colspan="1" rowspan="1">485.5</td><td colspan="1" rowspan="1">97.1%</td><td colspan="1" rowspan="1">400</td><td colspan="1" rowspan="1">380.7</td><td colspan="1" rowspan="1">95.2%</td></tr><tr><td colspan="1" rowspan="1">600</td><td colspan="1" rowspan="1">562.2</td><td colspan="1" rowspan="1">93.7%</td><td colspan="1" rowspan="1">500</td><td colspan="1" rowspan="1">489.4</td><td colspan="1" rowspan="1">97.9%</td></tr><tr><td colspan="1" rowspan="1">750</td><td colspan="1" rowspan="1">734.9</td><td colspan="1" rowspan="1">98.0%</td><td colspan="1" rowspan="1">600</td><td colspan="1" rowspan="1">564.8</td><td colspan="1" rowspan="1">94.1%</td></tr><tr><td colspan="1" rowspan="1">1000</td><td colspan="1" rowspan="1">926.9</td><td colspan="1" rowspan="1">92.7%</td><td colspan="1" rowspan="1">750</td><td colspan="1" rowspan="1">732.3</td><td colspan="1" rowspan="1">97.6%</td></tr><tr><td colspan="1" rowspan="1">1400</td><td colspan="1" rowspan="1">1340.8</td><td colspan="1" rowspan="1">95.8%</td><td colspan="1" rowspan="1">1000</td><td colspan="1" rowspan="1">974.9</td><td colspan="1" rowspan="1">97.5%</td></tr><tr><td colspan="1" rowspan="1">2000</td><td colspan="1" rowspan="1">1934.6</td><td colspan="1" rowspan="1">96.7%</td><td colspan="1" rowspan="1">1500</td><td colspan="1" rowspan="1">1552.3</td><td colspan="1" rowspan="1">103%</td></tr><tr><td colspan="3" rowspan="1"></td><td colspan="1" rowspan="1">2000</td><td colspan="1" rowspan="1">1894.9</td><td colspan="1" rowspan="1">94.7%</td></tr></table>

Linear regression analysis of the results yielded the following:

Amphetamine: $\mathrm { y } = 0 . 9 4 4 7 \mathrm { x } + 2 4 . 3 4$ , $\mathbf { r } ^ { 2 } = 0 . 9 9 7 8$ .   
Methamphetamine: $\mathrm { y } = 0 . 9 7 1 7 \mathrm { x } + 5 . 7 3 4$ , $\mathbf { r } ^ { 2 } = 0 . 9 9 7 1$ .

c. Traceability, Stability, Expected values (controls, calibrators, or methods): A stock solution of $1 0 0 0 ~ \mu \mathrm { g / m L }$ d-methamphetamine purchased from a commercial source is spiked into the calibrator and controls to the desired concentration. The concentration of the calibrator and controls are confirmed by GC/MS. The sponsor claimed an open vial stability of 18 months at 2 to $8 \mathrm { ^ \circ C }$ for the calibrator and control bottles. After the calibrator and control bottles are initially opened, the screw-on caps can be resealed.

d. Detection limit:

Performance at low drug concentrations in the semi-quantitative assay was characterized by determination of recovery (see section M1b above).

e. Analytical specificity:

The sponsor prepared urine-free samples spiked with d-amphetamine or dmethamphetamine at control levels $\pm 2 5 \%$ of the $5 0 0 ~ \mathrm { { n g / m L } }$ cutoff concentration) and evaluated the possible interference from endogenous compounds on the Hitachi 717 analyzer. No positive or negative interference due to endogenous compounds tested was observed. The results are listed below.

Endogenous Compounds Interference Data for d-amphetamine   

<table><tr><td colspan="1" rowspan="1">Compound</td><td colspan="1" rowspan="1">Concentration(mg/dL)</td><td colspan="1" rowspan="1">-25%d-amphetamine(375 ng/mL)</td><td colspan="1" rowspan="1">+25%d-amphetamine(625 ng/mL)</td></tr><tr><td colspan="1" rowspan="1">Acetone</td><td colspan="1" rowspan="1">1000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Ascorbic Acid</td><td colspan="1" rowspan="1">1500</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Creatinine</td><td colspan="1" rowspan="1">500</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Ethanol</td><td colspan="1" rowspan="1">1000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Galactose</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">γ-Globulin</td><td colspan="1" rowspan="1">500</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Glucose</td><td colspan="1" rowspan="1">1500</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Hemoglobin</td><td colspan="1" rowspan="1">300</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Human SerumAlbumin</td><td colspan="1" rowspan="1">500</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Oxalic Acid</td><td colspan="1" rowspan="1">100</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Riboflavin</td><td colspan="1" rowspan="1">2.5</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Sodium Chloride</td><td colspan="1" rowspan="1">6000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr><tr><td colspan="1" rowspan="1">Urea</td><td colspan="1" rowspan="1">2000</td><td colspan="1" rowspan="1">Negative</td><td colspan="1" rowspan="1">Positive</td></tr></table>

Endogenous Compounds Interference Data for ${ \mathrm { d } } \cdot { }$ -methamphetamine   

<table><tr><td rowspan=1 colspan=1>Compound</td><td rowspan=1 colspan=1>Concentration(mg/dL)</td><td rowspan=1 colspan=1>-25%d-methamphetamine(375 ng/mL)</td><td rowspan=1 colspan=1>+25%d-methamphetamine(625 ng/mL)</td></tr><tr><td rowspan=1 colspan=1>Acetone</td><td rowspan=1 colspan=1>1000</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Ascorbic Acid</td><td rowspan=1 colspan=1>1500</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Creatinine</td><td rowspan=1 colspan=1>500</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Ethanol</td><td rowspan=1 colspan=1>1000</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Galactose</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>γ-Globulin</td><td rowspan=1 colspan=1>500</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Glucose</td><td rowspan=1 colspan=1>1500</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Hemoglobin</td><td rowspan=1 colspan=1>300</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Human SerumAlbumin</td><td rowspan=1 colspan=1>500</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Oxalic Acid</td><td rowspan=1 colspan=1>100</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Riboflavin</td><td rowspan=1 colspan=1>2.5</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Sodium Chloride</td><td rowspan=1 colspan=1>6000</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Urea</td><td rowspan=1 colspan=1>2000</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>Positive</td></tr></table>

To test for possible positive and/or negative interference from specific gravity, the sponsor prepared samples containing d-amphetamine or ${ \mathrm { d } } \cdot { }$ -methamphetamine at control levels $( \pm 2 5 \%$ of the $5 0 0 ~ \mathrm { { n g / m L } }$ cutoff concentration) with specific gravities ranging from 1.002 to 1.030. No positive or negative interference due to specific gravity was observed.

To test for potential positive or negative interference from $\mathsf { p H }$ the sponsor prepared samples containing d-amphetamine or ${ \bf d } \cdot { \bf \partial }$ -methamphetamine at control levels $( \pm 2 5 \%$ of the $5 0 0 ~ \mathrm { { n g / m L } }$ cutoff concentration) with pH values of 3, 4.5, 5, 6, 7, 8 and 11. No negative interference due to $\mathsf { p H }$ was observed.

Cross reactivity of various potential interfering drugs were tested by spiking a final concentration of up to $5 0 0 , 0 0 0 \mathrm { n g / m L }$ of each substance into drug free urine, and then evaluated with the assay’s calibrated dose-response curve. The following table summarizes the approximate quantity of each compound that is equivalent in assay reactivity to the $5 0 0 ~ \mathrm { { n g / m L } }$ d-Methamphetamine cutoff. The sponsor claimed cross-reactivity with four compounds: PMA, MDA, MDMA, and Fenfluramine. The results are presented below.

Structurally Related Compounds Interference Data   

<table><tr><td>Compound</td><td>Concentration</td><td>Response equivalent</td><td>% Cross-</td></tr><tr><td></td><td>(ng/dL)</td><td>to cutoff (ng/mL)</td><td>reactivity</td></tr><tr><td colspan="1" rowspan="1">d-amphetamine</td><td colspan="1" rowspan="1">500</td><td colspan="1" rowspan="1">480.7</td><td colspan="1" rowspan="1">96.13%</td></tr><tr><td colspan="1" rowspan="1">d-methamphetamine</td><td colspan="1" rowspan="1">500</td><td colspan="1" rowspan="1">489.4</td><td colspan="1" rowspan="1">97.87%</td></tr><tr><td colspan="1" rowspan="1">1-Amphetamine</td><td colspan="1" rowspan="1">12,000</td><td colspan="1" rowspan="1">271.6</td><td colspan="1" rowspan="1">2.26%</td></tr><tr><td colspan="1" rowspan="1">Atomoxetine</td><td colspan="1" rowspan="1">500,000</td><td colspan="1" rowspan="1">75.2</td><td colspan="1" rowspan="1">0.02%</td></tr><tr><td colspan="1" rowspan="1">Benzphetamine</td><td colspan="1" rowspan="1">500,000</td><td colspan="1" rowspan="1">121.4</td><td colspan="1" rowspan="1">0.02%</td></tr><tr><td colspan="1" rowspan="1">d-Ephedrine</td><td colspan="1" rowspan="1">150,000</td><td colspan="1" rowspan="1">400.7</td><td colspan="1" rowspan="1">0.27%</td></tr><tr><td colspan="1" rowspan="1">1-Ephedrine</td><td colspan="1" rowspan="1">200,000</td><td colspan="1" rowspan="1">409.1</td><td colspan="1" rowspan="1">0.20%</td></tr><tr><td colspan="1" rowspan="1">Fenfluramine</td><td colspan="1" rowspan="1">4,000</td><td colspan="1" rowspan="1">433.3</td><td colspan="1" rowspan="1">10.83%</td></tr><tr><td colspan="1" rowspan="1">3-Hydroxy-Tyramine</td><td colspan="1" rowspan="1">500,000</td><td colspan="1" rowspan="1">300.5</td><td colspan="1" rowspan="1">0.06%</td></tr><tr><td colspan="1" rowspan="1">Isoxsuprine</td><td colspan="1" rowspan="1">500,000</td><td colspan="1" rowspan="1">83.9</td><td colspan="1" rowspan="1">0.02%</td></tr><tr><td colspan="1" rowspan="1">Mephentermine</td><td colspan="1" rowspan="1">25,000</td><td colspan="1" rowspan="1">57.4</td><td colspan="1" rowspan="1">0.23%</td></tr><tr><td colspan="1" rowspan="1">1-Methamphetamine</td><td colspan="1" rowspan="1">5,000</td><td colspan="1" rowspan="1">386.1</td><td colspan="1" rowspan="1">7.72%</td></tr><tr><td colspan="1" rowspan="1">para-Methoxyamphetamine (PMA)</td><td colspan="1" rowspan="1">400</td><td colspan="1" rowspan="1">433.8</td><td colspan="1" rowspan="1">108.44%</td></tr><tr><td colspan="1" rowspan="1">Methylenedioxyamphetamine (MDA)</td><td colspan="1" rowspan="1">1,400</td><td colspan="1" rowspan="1">306.0</td><td colspan="1" rowspan="1">21.85%</td></tr><tr><td colspan="1" rowspan="1">Methylenedioxyethylamphetamine(MDEA)</td><td colspan="1" rowspan="1">10,000</td><td colspan="1" rowspan="1">441.9</td><td colspan="1" rowspan="1">4.42%</td></tr><tr><td colspan="1" rowspan="1">Methylenedioxymethamphetamine(MDMA)</td><td colspan="1" rowspan="1">1,250</td><td colspan="1" rowspan="1">427.1</td><td colspan="1" rowspan="1">34.17%</td></tr><tr><td colspan="1" rowspan="1">Phendimetrazine</td><td colspan="1" rowspan="1">150,000</td><td colspan="1" rowspan="1">213.5</td><td colspan="1" rowspan="1">0.14%</td></tr><tr><td colspan="1" rowspan="1">Phenethylamine</td><td colspan="1" rowspan="1">25,000</td><td colspan="1" rowspan="1">411.4</td><td colspan="1" rowspan="1">1.65%</td></tr><tr><td colspan="1" rowspan="1">Phenmetrazine</td><td colspan="1" rowspan="1">40,000</td><td colspan="1" rowspan="1">313.2</td><td colspan="1" rowspan="1">0.78%</td></tr><tr><td colspan="1" rowspan="1">Phentermine</td><td colspan="1" rowspan="1">20,000</td><td colspan="1" rowspan="1">416.3</td><td colspan="1" rowspan="1">2.08%</td></tr><tr><td colspan="1" rowspan="1">Phenylephrine</td><td colspan="1" rowspan="1">400,000</td><td colspan="1" rowspan="1">453.4</td><td colspan="1" rowspan="1">0.11%</td></tr><tr><td colspan="1" rowspan="1">d,1-Phenylpropanolamine</td><td colspan="1" rowspan="1">150,000</td><td colspan="1" rowspan="1">403.9</td><td colspan="1" rowspan="1">0.27%</td></tr><tr><td colspan="1" rowspan="1">d-Pseudoephedrine</td><td colspan="1" rowspan="1">150,000</td><td colspan="1" rowspan="1">422.3</td><td colspan="1" rowspan="1">0.28%</td></tr><tr><td colspan="1" rowspan="1">1-Pseudoephedrine</td><td colspan="1" rowspan="1">200,000</td><td colspan="1" rowspan="1">106.9</td><td colspan="1" rowspan="1">0.05%</td></tr><tr><td colspan="1" rowspan="1">Tranylcypromine</td><td colspan="1" rowspan="1">50,000</td><td colspan="1" rowspan="1">399.1</td><td colspan="1" rowspan="1">0.80%</td></tr><tr><td colspan="1" rowspan="1">Tyramine</td><td colspan="1" rowspan="1">400,000</td><td colspan="1" rowspan="1">423.5</td><td colspan="1" rowspan="1">0.11%</td></tr></table>

Structurally Unrelated Compounds Interference Data   

<table><tr><td colspan="1" rowspan="1">Compound</td><td colspan="1" rowspan="1">Concentration(ng/dL)</td><td colspan="1" rowspan="1">Response equivalentto cutoff (ng/mL)</td><td colspan="1" rowspan="1">% Cross-reactivity</td></tr><tr><td colspan="1" rowspan="1">Acetaminophen</td><td colspan="1" rowspan="1">500,000</td><td colspan="1" rowspan="1">108.6</td><td colspan="1" rowspan="1">0.02 %</td></tr><tr><td colspan="1" rowspan="1">Acetylsalicylic acid</td><td colspan="1" rowspan="1">500,000</td><td colspan="1" rowspan="1">97.8</td><td colspan="1" rowspan="1">0.02 %</td></tr><tr><td colspan="1" rowspan="1">Amobarbital</td><td colspan="1" rowspan="1">500,000</td><td colspan="1" rowspan="1">100.1</td><td colspan="1" rowspan="1">0.02 %</td></tr><tr><td colspan="1" rowspan="1">Benzoylecgonine</td><td colspan="1" rowspan="1">500,000</td><td colspan="1" rowspan="1">103.1</td><td colspan="1" rowspan="1">0.02 %</td></tr><tr><td colspan="1" rowspan="1">Bromopheniramine</td><td colspan="1" rowspan="1">500,000</td><td colspan="1" rowspan="1">125.0</td><td colspan="1" rowspan="1">0.02 %</td></tr><tr><td colspan="1" rowspan="1">Bupropion</td><td colspan="1" rowspan="1">500,000</td><td colspan="1" rowspan="1">194.0</td><td colspan="1" rowspan="1">0.04 %</td></tr><tr><td colspan="1" rowspan="1">Buspiron</td><td colspan="1" rowspan="1">500,000</td><td colspan="1" rowspan="1">170.0</td><td colspan="1" rowspan="1">0.03 %</td></tr><tr><td colspan="1" rowspan="1">Caffeine</td><td colspan="1" rowspan="1">500,000</td><td colspan="1" rowspan="1">105.1</td><td colspan="1" rowspan="1">0.02 %</td></tr><tr><td colspan="1" rowspan="1">Chlorpheniramine</td><td colspan="1" rowspan="1">500,000</td><td colspan="1" rowspan="1">129.7</td><td colspan="1" rowspan="1">0.03 %</td></tr><tr><td colspan="1" rowspan="1">Chlorpromazine</td><td colspan="1" rowspan="1">500,000</td><td colspan="1" rowspan="1">159.7</td><td colspan="1" rowspan="1">0.03 %</td></tr><tr><td colspan="1" rowspan="1">Codeine</td><td colspan="1" rowspan="1">500,000</td><td colspan="1" rowspan="1">109.4</td><td colspan="1" rowspan="1">0.02 %</td></tr><tr><td colspan="1" rowspan="1">Dextromethorphan</td><td colspan="1" rowspan="1">500,000</td><td colspan="1" rowspan="1">107.2</td><td colspan="1" rowspan="1">0.02 %</td></tr><tr><td colspan="1" rowspan="1">Doxepine</td><td colspan="1" rowspan="1">500,000</td><td colspan="1" rowspan="1">240.4</td><td colspan="1" rowspan="1">0.05 %</td></tr><tr><td colspan="1" rowspan="1">Meperidine</td><td colspan="1" rowspan="1">500,000</td><td colspan="1" rowspan="1">30.8</td><td colspan="1" rowspan="1">0.01 %</td></tr><tr><td colspan="1" rowspan="1">Methadone</td><td colspan="1" rowspan="1">500,000</td><td colspan="1" rowspan="1">121.2</td><td colspan="1" rowspan="1">0.02 %</td></tr><tr><td colspan="1" rowspan="1">Methapyrilene</td><td colspan="1" rowspan="1">500,000</td><td colspan="1" rowspan="1">191.5</td><td colspan="1" rowspan="1">0.04 %</td></tr><tr><td colspan="1" rowspan="1">Methaqualone</td><td colspan="1" rowspan="1">500,000</td><td colspan="1" rowspan="1">101.6</td><td colspan="1" rowspan="1">0.02 %</td></tr><tr><td colspan="1" rowspan="1">Morphine</td><td colspan="1" rowspan="1">500,000</td><td colspan="1" rowspan="1">62.9</td><td colspan="1" rowspan="1">0.01 %</td></tr><tr><td colspan="1" rowspan="1">Oxazepam</td><td colspan="1" rowspan="1">500,000</td><td colspan="1" rowspan="1">101.2</td><td colspan="1" rowspan="1">0.02 %</td></tr><tr><td colspan="1" rowspan="1">Phencyclidine</td><td colspan="1" rowspan="1">500,000</td><td colspan="1" rowspan="1">29.3</td><td colspan="1" rowspan="1">0.01 %</td></tr><tr><td colspan="1" rowspan="1">Phenobarbital</td><td colspan="1" rowspan="1">500,000</td><td colspan="1" rowspan="1">99.7</td><td colspan="1" rowspan="1">0.02 %</td></tr><tr><td colspan="1" rowspan="1">Phenothiazine</td><td colspan="1" rowspan="1">500,000</td><td colspan="1" rowspan="1">65.0</td><td colspan="1" rowspan="1">0.01 %</td></tr><tr><td colspan="1" rowspan="1">Procainamide</td><td colspan="1" rowspan="1">500,000</td><td colspan="1" rowspan="1">412.4</td><td colspan="1" rowspan="1">0.08 %</td></tr><tr><td colspan="1" rowspan="1">Promethazine</td><td colspan="1" rowspan="1">500,000</td><td colspan="1" rowspan="1">122.0</td><td colspan="1" rowspan="1">0.02 %</td></tr><tr><td colspan="1" rowspan="1">Propoxyphene</td><td colspan="1" rowspan="1">500,000</td><td colspan="1" rowspan="1">92.2</td><td colspan="1" rowspan="1">0.02 %</td></tr><tr><td colspan="1" rowspan="1">Propranolol</td><td colspan="1" rowspan="1">500,000</td><td colspan="1" rowspan="1">102.3</td><td colspan="1" rowspan="1">0.02 %</td></tr><tr><td colspan="1" rowspan="1">Ranitidine</td><td colspan="1" rowspan="1">80,000</td><td colspan="1" rowspan="1">799.8</td><td colspan="1" rowspan="1">1.00 %</td></tr><tr><td colspan="1" rowspan="1">Scopolamine</td><td colspan="1" rowspan="1">500,000</td><td colspan="1" rowspan="1">105.6</td><td colspan="1" rowspan="1">0.02 %</td></tr><tr><td colspan="1" rowspan="1">Secobarbital</td><td colspan="1" rowspan="1">500,000</td><td colspan="1" rowspan="1">92.3</td><td colspan="1" rowspan="1">0.02 %</td></tr><tr><td colspan="1" rowspan="1">Sertraline</td><td colspan="1" rowspan="1">500,000</td><td colspan="1" rowspan="1">194.1</td><td colspan="1" rowspan="1">0.04 %</td></tr><tr><td colspan="1" rowspan="1">Thioridazine</td><td colspan="1" rowspan="1">500,000</td><td colspan="1" rowspan="1">103.6</td><td colspan="1" rowspan="1">0.02 %</td></tr><tr><td colspan="1" rowspan="1">Trazodone</td><td colspan="1" rowspan="1">500,000</td><td colspan="1" rowspan="1">251.6</td><td colspan="1" rowspan="1">0.05 %</td></tr><tr><td colspan="1" rowspan="1">Trifluoperazine</td><td colspan="1" rowspan="1">500,000</td><td colspan="1" rowspan="1">123.0</td><td colspan="1" rowspan="1">0.02 %</td></tr><tr><td colspan="1" rowspan="1">Trifluopromazine</td><td colspan="1" rowspan="1">500,000</td><td colspan="1" rowspan="1">127.8</td><td colspan="1" rowspan="1">0.03 %</td></tr><tr><td colspan="1" rowspan="1">Valproic Acid</td><td colspan="1" rowspan="1">500,000</td><td colspan="1" rowspan="1">88.3</td><td colspan="1" rowspan="1">0.02 %</td></tr></table>

f. Assay cut-off:

There is a $5 0 0 ~ \mathrm { { n g / m L } }$ cutoff concentration claimed for both d-amphetamine and methamphetamine.

2. Comparison studies:

a. Method comparison with predicate device:

The sponsor conducted two separate method comparison studies to evaluate the performance of the device for detection of d-methamphetamine or damphetamine. For method comparison study for the detection of amphetamine, one hundred and eleven unaltered samples (55 negative and 56 positive samples) were tested with LZI Amphetamines 500 Enzyme Immunoassay on the Hitachi 717 analyzer and compared against the results (d-amphetamine and d-methamphetamine concentration) obtained with GC/MS or LC/MS. The results of the studies are presented below:

Summary of Discordant Results (Semi-Quantitative)   

<table><tr><td rowspan=1 colspan=6>Semi-Quantitative Method Comparison Data for Amphetamine500 ng/mL Cutoff</td></tr><tr><td rowspan=1 colspan=1>CandidateDeviceResults</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>&lt;50 % of thecutoffconcentration(1-250 ng/mL)</td><td rowspan=1 colspan=1>Near NegativeCutoff(250-500 ng/mL)</td><td rowspan=1 colspan=1>Near PositiveCutoff(500-750 ng/mL)</td><td rowspan=1 colspan=1>High Positive(&gt;750 ng/mL)</td></tr><tr><td rowspan=1 colspan=1>Positive(56 samples)</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>45</td></tr><tr><td rowspan=1 colspan=1>Negative(55 samples)</td><td rowspan=1 colspan=1>12</td><td rowspan=1 colspan=1>22</td><td rowspan=1 colspan=1>21</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0</td></tr></table>

<table><tr><td rowspan=1 colspan=1>Assay</td><td rowspan=1 colspan=1>Cutoff Value(ng/mL)</td><td rowspan=1 colspan=1>CandidateDevice Result</td><td rowspan=1 colspan=1>GC/MS or LC/MS result</td></tr><tr><td rowspan=1 colspan=1>Amphetamine</td><td rowspan=1 colspan=1>500</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>531 ng/mL amphetamine0 ng/mL methamphetamine</td></tr></table>

<table><tr><td rowspan=1 colspan=6>Qualitative Method Comparison Data for Amphetamine500 ng/mL Cutoff</td></tr><tr><td rowspan=1 colspan=1>CandidateDeviceResults</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>&lt;50 % of thecutoffconcentration(1-250 ng/mL)</td><td rowspan=1 colspan=1>Near NegativeCutoff(250-500 ng/mL)</td><td rowspan=1 colspan=1>Near PositiveCutoff(500-750 ng/mL)</td><td rowspan=1 colspan=1>High Positive(&gt;750 ng/mL)</td></tr><tr><td rowspan=1 colspan=1>Positive(56 samples)</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>9</td><td rowspan=1 colspan=1>45</td></tr><tr><td rowspan=1 colspan=1>Negative(55 samples)</td><td rowspan=1 colspan=1>12</td><td rowspan=1 colspan=1>22</td><td rowspan=1 colspan=1>21</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>0</td></tr></table>

Summary of Discordant Results (Qualitative)   

<table><tr><td rowspan=1 colspan=1>Assay</td><td rowspan=1 colspan=1>Cutoff Value(ng/mL)</td><td rowspan=1 colspan=1>CandidateDevice Result</td><td rowspan=1 colspan=1>GC/MS or LC/MS result</td></tr><tr><td rowspan=1 colspan=1>Amphetamine</td><td rowspan=1 colspan=1>500</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>510 ng/mL amphetamine0 ng/mL methamphetamine</td></tr><tr><td rowspan=1 colspan=1>Amphetamine</td><td rowspan=1 colspan=1>500</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>531 ng/mL amphetamine0 ng/mL methamphetamine</td></tr></table>

For method comparison study for the detection of methamphetamine, eightysix unaltered samples (43 negative and 43 positive samples) were tested with LZI Amphetamines 500 Enzyme Immunoassay on the Hitachi 717 analyzer and compared against the results (d-amphetamine and d-methamphetamine concentration) obtained with GC/MS or LC/MS. The results of the studies are presented below:

<table><tr><td rowspan=1 colspan=6>Semi-Quantitative Method Comparison Data for Methamphetamine500 ng/mL Cutoff</td></tr><tr><td rowspan=1 colspan=1>CandidateDeviceResults</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>&lt;50 % of thecutoffconcentration(1-250 ng/mL)</td><td rowspan=1 colspan=1>Near NegativeCutoff(250-500 ng/mL)</td><td rowspan=1 colspan=1>Near PositiveCutoff(500-750 ng/mL)</td><td rowspan=1 colspan=1>High Positive(&gt;750 ng/mL)</td></tr><tr><td rowspan=1 colspan=1>Positive(43 samples)</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>4</td><td rowspan=1 colspan=1>10</td><td rowspan=1 colspan=1>9</td><td rowspan=1 colspan=1>34</td></tr><tr><td rowspan=1 colspan=1>Negative(43 samples)</td><td rowspan=1 colspan=1>4</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>5</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td></tr></table>

Summary of Discordant Results (Semi-Quantitative)   

<table><tr><td rowspan=1 colspan=1>Assay</td><td rowspan=1 colspan=1>Cutoff Value(ng/mL)</td><td rowspan=1 colspan=1>CandidateDevice Result</td><td rowspan=1 colspan=1>GC/MS or LC/MS result</td></tr><tr><td rowspan=1 colspan=1>Methamphetamine</td><td rowspan=1 colspan=1>500</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>16 ng/mL methamphetamine584 ng/mL amphetamine</td></tr><tr><td rowspan=1 colspan=1>Methamphetamine</td><td rowspan=1 colspan=1>500</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>114 ng/mL methamphetamine621 ng/mL amphetamine</td></tr><tr><td rowspan=1 colspan=1>Methamphetamine</td><td rowspan=1 colspan=1>500</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>133 ng/mL methamphetamine1029 ng/mL amphetamine</td></tr><tr><td rowspan=1 colspan=1>Methamphetamine</td><td rowspan=1 colspan=1>500</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>184 ng/mL methamphetamine957 ng/mL amphetamine</td></tr><tr><td rowspan=1 colspan=1>Methamphetamine</td><td rowspan=1 colspan=1>500</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>269 ng/mL methamphetamine397 ng/mL amphetamine</td></tr><tr><td rowspan=1 colspan=1>Methamphetamine</td><td rowspan=1 colspan=1>500</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>306 ng/mL methamphetamine244 ng/mL amphetamine</td></tr><tr><td rowspan=1 colspan=1>Methamphetamine</td><td rowspan=1 colspan=1>500</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>385 ng/mL methamphetamine235 ng/mL amphetamine</td></tr><tr><td rowspan=1 colspan=1>Methamphetamine</td><td rowspan=1 colspan=1>500</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>388 ng/mL methamphetamine178 ng/mL amphetamine</td></tr><tr><td rowspan=1 colspan=1>Methamphetamine</td><td rowspan=1 colspan=1>500</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>402 ng/mL methamphetamine226 ng/mL amphetamine</td></tr><tr><td rowspan=1 colspan=1>Methamphetamine</td><td rowspan=1 colspan=1>500</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>409 ng/mL methamphetamine147 ng/mL amphetamine</td></tr><tr><td rowspan=1 colspan=1>Methamphetamine</td><td rowspan=1 colspan=1>500</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>413 ng/mL methamphetamine708 ng/mL amphetamine</td></tr><tr><td rowspan=1 colspan=1>Methamphetamine</td><td rowspan=1 colspan=1>500</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>413 ng/mL methamphetamine130 ng/mL amphetamine</td></tr><tr><td rowspan=1 colspan=1>Methamphetamine</td><td rowspan=1 colspan=1>500</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>458 ng/mL methamphetamine180 ng/mL amphetamine</td></tr><tr><td rowspan=1 colspan=1>Methamphetamine</td><td rowspan=1 colspan=1>500</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>471 ng/mL methamphetamine108 ng/mL amphetamine</td></tr></table>

<table><tr><td rowspan=1 colspan=6>Qualitative Method Comparison Data for Methamphetamine500 ng/mL Cutoff</td></tr><tr><td rowspan=1 colspan=1>CandidateDeviceResults</td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>&lt;50 % of thecutoffconcentration(1-250 ng/mL)</td><td rowspan=1 colspan=1>Near NegativeCutoff(250-500 ng/mL)</td><td rowspan=1 colspan=1>Near PositiveCutoff(500-750 ng/mL)</td><td rowspan=1 colspan=1>High Positive(&gt;750 ng/mL)</td></tr><tr><td rowspan=1 colspan=1>Positive(43 samples)</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>4</td><td rowspan=1 colspan=1>9</td><td rowspan=1 colspan=1>9</td><td rowspan=1 colspan=1>34</td></tr><tr><td rowspan=1 colspan=1>Negative(43 samples)</td><td rowspan=1 colspan=1>4</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>6</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td></tr></table>

Summary of Discordant Results (Qualitative)   

<table><tr><td colspan="1" rowspan="1">Assay</td><td colspan="1" rowspan="1">Cutoff Value(ng/mL)</td><td colspan="1" rowspan="1">CandidateDevice Result</td><td colspan="1" rowspan="1">GC/MS or LC/MS result</td></tr><tr><td colspan="1" rowspan="1">Methamphetamine</td><td colspan="1" rowspan="1">500</td><td colspan="1" rowspan="1">Positive</td><td colspan="1" rowspan="1">16 ng/mL methamphetamine584 ng/mL amphetamine</td></tr><tr><td colspan="1" rowspan="1">Methamphetamine</td><td colspan="1" rowspan="1">500</td><td colspan="1" rowspan="1">Positive</td><td colspan="1" rowspan="1">114 ng/mL methamphetamine621 ng/mL amphetamine</td></tr><tr><td colspan="1" rowspan="1">Methamphetamine</td><td colspan="1" rowspan="1">500</td><td colspan="1" rowspan="1">Positive</td><td colspan="1" rowspan="1">133 ng/mL methamphetamine1029 ng/mL amphetamine</td></tr><tr><td colspan="1" rowspan="1">Methamphetamine</td><td colspan="1" rowspan="1">500</td><td colspan="1" rowspan="1">Positive</td><td colspan="1" rowspan="1">184 ng/mL methamphetamine957 ng/mL amphetamine</td></tr><tr><td colspan="1" rowspan="1">Methamphetamine</td><td colspan="1" rowspan="1">500</td><td colspan="1" rowspan="1">Positive</td><td colspan="1" rowspan="1">269 ng/mL methamphetamine397 ng/mL amphetamine</td></tr><tr><td colspan="1" rowspan="1">Methamphetamine</td><td colspan="1" rowspan="1">500</td><td colspan="1" rowspan="1">Positive</td><td colspan="1" rowspan="1">306 ng/mL methamphetamine244 ng/mL amphetamine</td></tr><tr><td colspan="1" rowspan="1">Methamphetamine</td><td colspan="1" rowspan="1">500</td><td colspan="1" rowspan="1">Positive</td><td colspan="1" rowspan="1">385 ng/mL methamphetamine235 ng/mL amphetamine</td></tr><tr><td colspan="1" rowspan="1">Methamphetamine</td><td colspan="1" rowspan="1">500</td><td colspan="1" rowspan="1">Positive</td><td colspan="1" rowspan="1">388 ng/mL methamphetamine178 ng/mL amphetamine</td></tr><tr><td colspan="1" rowspan="1">Methamphetamine</td><td colspan="1" rowspan="1">500</td><td colspan="1" rowspan="1">Positive</td><td colspan="1" rowspan="1">409 ng/mL methamphetamine147 ng/mL amphetamine</td></tr><tr><td colspan="1" rowspan="1">Methamphetamine</td><td colspan="1" rowspan="1">500</td><td colspan="1" rowspan="1">Positive</td><td colspan="1" rowspan="1">413 ng/mL methamphetamine708 ng/mL amphetamine</td></tr><tr><td colspan="1" rowspan="1">Methamphetamine</td><td colspan="1" rowspan="1">500</td><td colspan="1" rowspan="1">Positive</td><td colspan="1" rowspan="1">413 ng/mL methamphetamine130 ng/mL amphetamine</td></tr><tr><td colspan="1" rowspan="1">Methamphetamine</td><td colspan="1" rowspan="1">500</td><td colspan="1" rowspan="1">Positive</td><td colspan="1" rowspan="1">458 ng/mL methamphetamine180 ng/mL amphetamine</td></tr><tr><td colspan="1" rowspan="1">Methamphetamine</td><td colspan="1" rowspan="1">500</td><td colspan="1" rowspan="1">Positive</td><td colspan="1" rowspan="1">471 ng/mL methamphetamine108 ng/mL amphetamine</td></tr></table>

$b$ . Matrix comparison: Not applicable

3. Clinical studies:

a. Clinical Sensitivity: Not applicable   
b. Clinical specificity: Not applicable   
c. Other clinical supportive data (when a. and b. are not applicable): Not applicable

4. Clinical cut-off: Not applicable

5. Expected values/Reference range: Not applicable

N. Proposed Labeling: The labeling is sufficient and it satisfies the requirements of 21 CFR Part 809.10.

# O. Conclusion:

The submitted information in this premarket notification is complete and supports a substantial equivalence decision.